Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 4,352,318 |
|
|||||
| News | - | ||||||
| Day High | 0.245 | Low High |
|||||
| Day Low | 0.2042 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kintara Therapeutics Inc | KTRA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0459 | -17.87% | 0.2109 | 18:58:47 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.2383 | 0.2042 | 0.245 | 0.2103 | 0.2568 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,687 | 4,352,318 | US$ 0.2236152 | US$ 973,244 | - | 0.081 - 5.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:58:47 | formt | 100 | US$ 0.2109 | USD |
Kintara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.2M | 39.04M | - | 0 | -15.02M | -0.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kintara Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KTRA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.2726 | 0.354 | 0.1925 | 0.2732594 | 14,158,648 | -0.0617 | -22.63% |
| 1 Month | 0.16 | 0.417 | 0.125 | 0.2372881 | 20,544,521 | 0.0509 | 31.81% |
| 3 Months | 0.099999 | 0.417 | 0.086 | 0.1867063 | 15,021,781 | 0.1109 | 110.90% |
| 6 Months | 0.3086 | 0.417 | 0.081 | 0.1604267 | 13,365,541 | -0.0977 | -31.66% |
| 1 Year | 3.13 | 5.60 | 0.081 | 0.1910289 | 6,846,099 | -2.92 | -93.26% |
| 3 Years | 82.50 | 142.50 | 0.081 | 7.26 | 3,279,715 | -82.29 | -99.74% |
| 5 Years | 60.50 | 167.50 | 0.081 | 12.25 | 2,746,007 | -60.29 | -99.65% |
Kintara Therapeutics Description
| Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. |
